Monday, Dec 18, 2017
engineered enzymes for better healthcare

Enzolve Technologies’ highly innovative diagnostic product, the NeoScreenPak, is a suite of tests for screening newborn babies for 7 out of the 11 most commonly screened disorders. These tests will be carried out on a simple single platform that can replace a number of diverse, and often quite complex, technologies currently used world-wide for screening such disorders.

More info…

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...